Building Safety Substantiation for One Product Line
A worked walkthrough of assembling MoCRA safety substantiation for a small-batch product line, from existing ingredient data through toxicologist review.
Let's say you run a small-batch line of four body butters, all built on the same base with different botanical additions and fragrances. You've heard the term "safety substantiation" thrown around in MoCRA conversations and you're not sure what actually needs to exist in a folder before you can say you have it. Here's how that assembly actually goes for a line this size.
What safety substantiation is, functionally
Under MoCRA, the responsible person needs to ensure there's adequate substantiation that a cosmetic product is safe for its intended use. It's not a specific government-issued certificate. It's a body of evidence, built from existing data, testing, and expert review, that supports the safety conclusion for that specific product as formulated. The obligation is on you to have it ready and organized, not to submit it somewhere for pre-approval, since MoCRA doesn't require pre-market approval of cosmetic products.
Step 1: Start with what already exists for each ingredient
For a body butter line, you're likely working with a fairly small, well-characterized ingredient set: shea butter, various carrier oils, an emulsifier, a preservative system, botanical extracts, fragrance oils. Most of these ingredients already have substantial existing safety data behind them, because they're used across the industry at scale.
Pull together, for each ingredient:
- Safety data sheets, checking section 3 for composition detail
- Any supplier-provided toxicology summaries or safety assessments
- Published safety review data where available (several independent bodies publish cosmetic ingredient safety reviews that are commonly referenced in the industry)
- Historical use levels and any known restrictions
This existing data does a lot of the substantiation work for you. You're rarely starting from zero on well-established ingredients like shea butter or common carrier oils.
Step 2: Document the actual finished formula, precisely
Substantiation is specific to your product as formulated, not to the ingredients in the abstract. This means:
- The full ingredient list with real percentages
- Any supplier blends expanded into their actual components, since a preservative or fragrance blend's real composition matters for a safety conclusion, not just its trade name
- The product's intended use (a body butter applied topically, left on, is a different exposure scenario than a rinse-off product)
- The intended user population, and any specific claims made about the product
For a four-product line sharing one base, this step is efficient. The shared base ingredients only need to be documented once, and each variant's substantiation package mainly needs to address what's different: the specific botanical addition and fragrance in each one.
Step 3: Identify what's genuinely novel
Most of a well-formulated small-batch line will be existing, well-characterized ingredients at conventional use levels. What needs closer attention is anything that's less conventional: a newer botanical extract without a long history of cosmetic use, an unusually high usage level for something, or a novel combination that hasn't specifically been assessed together before. Flag these honestly rather than assuming existing single-ingredient data automatically covers a novel combination or an elevated use level.
Step 4: Bring in a qualified reviewer
This is the step small-batch makers most often skip or shortcut, and it's the one that actually anchors the substantiation. A toxicologist or other qualified safety assessor reviewing your compiled formula, ingredient data, and intended use, and providing a documented professional opinion that the product is safe as formulated, is what turns a folder of ingredient data sheets into an actual substantiation file. Existing ingredient safety data supports the conclusion; the qualified review is what makes the conclusion defensible.
For a line this size, this doesn't have to mean an enormous engagement. Many independent safety assessors and consultants work with small-batch brands specifically on substantiation review at a scale that fits a four-product line, particularly when the ingredients are largely conventional.
Step 5: Keep it organized and current
A substantiation file isn't a one-time deliverable you file away. If you change a fragrance supplier, adjust a percentage, or add a fifth product to the line using a new ingredient, that changes what needs substantiation. Keep the file structured so it's clear which parts apply to the shared base and which are specific to each variant, so an update to one product doesn't require rebuilding the whole file.
A simple structure to work from
| Component | Where it comes from |
|---|---|
| Ingredient-level safety data | Supplier SDS, published safety reviews, existing toxicology data |
| Finished formula documentation | Your own batch records, with blends expanded to real percentages |
| Intended use and exposure scenario | Your product's actual claims and use instructions |
| Qualified safety assessor review | A toxicologist or safety assessor's documented opinion |
| Adverse event recordkeeping process | Your own system for logging and responding to consumer reports |
Where this connects to notification and listing
Safety substantiation sits alongside, but separate from, product listing obligations under MoCRA. Cosmetic Comply's current focus is the notification side of this world, matching ingredients to INCI names and CAS numbers, screening against restricted lists, and filing, starting with Canada's CNF process, with US listing support on the way. The ingredient-level groundwork, precise INCI mapping and real percentages, feeds directly into a cleaner substantiation file regardless of which market's paperwork you're ultimately assembling it for.
Send your ingredients and we take it from here
A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.
Start a filingKeep reading
Common Cosmetics Direct Submission Errors to Avoid
A troubleshooting list of the frequent mistakes that cause rejected or inaccurate MoCRA product listings, and how to fix each one.
Fragrance Allergen Labeling and the April 12 2026 List
What Canada's List 1 fragrance allergen disclosure means for your CNF and label starting April 12, 2026, and how to check your formula now.
How to List Multiple Products Under One Facility
A practical workflow for listing a growing catalog with the FDA under MoCRA without duplicating work or losing track of facility numbers.
Private Label Brands and Who Owns MoCRA Compliance
Working through a private label scenario to pin down who is legally the responsible person under MoCRA when reselling a stock formula.